Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease prostate cancer
Symptom C0028754|obesity
Sentences 34
PubMedID- 20800152 Background: previous studies suggest that obesity is associated with higher prostate cancer progression and mortality despite an association with lower prostate cancer incidence.
PubMedID- 21258401 Although the underlying biological mechanism is not fully understood, it has been speculated that the association of obesity with increasing prostate cancer aggressiveness may be resulted from endocrine derangements (irigaray et al., 2007; o’malley and taneja, 2006).
PubMedID- 21266978 Association of obesity with prostate cancer: a case-control study within the population-based psa testing phase of the protect study.
PubMedID- 25261967 In univariable analysis, obesity was not associated with high-grade prostate cancer (or, 1.08; p = 0.50).
PubMedID- 21369380 9 some studies in western literature have shown an association of high-grade prostate cancer with central obesity, hyperinsulinemia, and dyslipidemia.
PubMedID- 25877612 Background: recent evidence suggests a particular role for obesity in prostate cancer (pca) progression.
PubMedID- 22469146 Background: obesity is associated with prostate cancer aggressiveness and mortality.
PubMedID- 23820091 We evaluated the association between obesity and mets with prostate cancer pathology and surgical and functional outcomes.
PubMedID- 26181179 Difference in association of obesity with prostate cancer risk between us african american and non-hispanic white men in the selenium and vitamin e cancer prevention trial (select).
PubMedID- 21458309 Conclusions: although obesity has been associated with more aggressive prostate cancer, bmi does not appear to have statistically significant influence on the rate and location of psm in rlrp.
PubMedID- 23009325 Recent studies demonstrated that obesity is associated with prostate cancer aggressiveness and prognosis.
PubMedID- 25822612 While evidence is accumulating about the association of obesity with prostate cancer aggressiveness and poor clinical outcomes , little is known about any influence of body composition on clinical benefits of specific therapies for prostate cancer.
PubMedID- 22921964 This provides further support for the idea that obesity is biologically associated with prostate cancer progression.
PubMedID- 24272675 Among other findings, it was proven that obesity increases the risk of more aggressive prostate cancer , and developing benign prostate hyperplasia (bph) 4.
PubMedID- 20404514 Findings from epidemiological studies correlating obesity, the sources of dietary fat and prostate cancer (pca) are conflicting.
PubMedID- 22690216 Leptin may be a potential link between obesity and risk of progression of prostate cancer.
PubMedID- 21397927 Circulating levels of adiponectin, a protein involved in insulin resistance and obesity, have been associated with prostate cancer risk.
PubMedID- 26387087 Background: epidemiological studies suggest a potential role for obesity and determinants of adult stature in prostate cancer risk and mortality, but the relationships described in the literature are complex.
PubMedID- 26373570 Herein, we summarize epidemiologic and preclinical evidence for an association between obesity and increased risk of breast and prostate cancer incidence and mortality.
PubMedID- 25903805 Background: there is evidence that obesity is associated with an aggressive prostate cancer (pc).
PubMedID- 26181184 Objective: to determine whether the association of obesity with prostate cancer risk differs between african american and non-hispanic white men and whether obesity modifies the excess risk associated with african american race.
PubMedID- 24865433 Corpulence is the crucial factor: association of testosterone and/or obesity with prostate cancer stage.
PubMedID- 25737954 While some studies show a modest increase in the risk of high grade prostate cancer with obesity .
PubMedID- 20507889 Although obesity is not associated with prostate cancer incidence overall, it is associated with fatal and aggressive disease 6.
PubMedID- 22249290 Background: emerging data suggest that obesity increases the risk of aggressive prostate cancer (pc), but the mechanisms underlying this relationship remain to be fully elucidated.
PubMedID- 20033185 Objective: several reports found that obesity was associated with prostate cancer (pc) aggressiveness among men treated with radical prostatectomy or radiotherapy.
PubMedID- 21198939 Relationship between prostate-specific antigen and obesity in prostate cancer screening: analysis of a large cohort in japan.
PubMedID- 24292212 Conclusions: these results suggest that obesity is linked with poorer prostate cancer prognosis primarily in men with tumors harboring the gene fusion tmprss2:erg.
PubMedID- 21242331 Impact: the inverse association of obesity with prostate cancer diagnosis may be at least partly due to detection bias, which is due to larger prostate volumes and psa hemodilution in obese men.
PubMedID- 24240026 Incidence of skeletal metastases and death from prostate cancer greatly increases with age and obesity, conditions which increase marrow adiposity.
PubMedID- 23710344 They were able to estimate how obesity increases the risk of prostate cancer and that despite the overall decreases in prostate cancer mortality, the declines were limited by the increase in obesity.
PubMedID- 20367635 Objective: to analyse the relationship between african american (aa) race and obesity in men with prostate cancer.
PubMedID- 20697428 The absence of any significant association between obesity and diabetes with prostate cancer in this population has been reported previously(21).
PubMedID- 24769031 However, only mild obesity was significantly associated with prostate cancer specific survival (hr 1.51, p = 0.040), whereas moderate/severe obesity was not (hr 1.58, p = 0.356).

Page: 1